Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Open Access
- 14 April 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (8), 3351-3360
- https://doi.org/10.1158/0008-5472.can-09-4235
Abstract
Circadian disruption accelerates cancer progression, whereas circadian reinforcement could halt it. Mice with P03 pancreatic adenocarcinoma (n = 77) were synchronized and fed ad libitum (AL) or with meal timing (MT) from Zeitgeber time (ZT) 2 to ZT6 with normal or fat diet. Tumor gene expression profiling was determined with DNA microarrays at endogenous circadian time (CT) 4 and CT16. Circadian mRNA expression patterns were determined for clock genes Rev-erbα, Per2, and Bmal1, cellular stress genes Hspa8 and Cirbp, and cyclin A2 gene Ccna2 in liver and tumor. The 24-hour patterns in telemetered rest-activity and body temperature and plasma corticosterone and insulin-like growth factor-I (IGF-I) were assessed. We showed that MT inhibited cancer growth by ∼40% as compared with AL (P = 0.011) irrespective of calorie intake. Clock gene transcription remained arrhythmic in tumors irrespective of feeding schedule or diet. Yet, MT upregulated or downregulated the expression of 423 tumor genes, according to CT. Moreover, 36 genes involved in cellular stress, cell cycle, and metabolism were upregulated at one CT and downregulated 12 h apart. MT induced >10-fold circadian expression of Hspa8, Cirbp, and Ccna2 in tumors. Corticosterone or IGF-I patterns played no role in tumor growth inhibition. In contrast, MT consistently doubled the circadian amplitude of body temperature. Peak and trough respectively corresponded to peak expressions of Hspa8 and Cirbp in tumors. The reinforcement of the host circadian timing system with MT induced 24-hour rhythmic expression of critical genes in clock-deficient tumors, which translated into cancer growth inhibition. Targeting circadian clocks represents a novel potential challenge for cancer therapeutics. Cancer Res; 70(8); 3351–60. ©2010 AACR.Keywords
Other Versions
This publication has 40 references indexed in Scilit:
- Metabolism and cancer: the circadian clock connectionNature Reviews Cancer, 2009
- Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal CancerCancer Research, 2009
- Disruption of the circadian clock due to theClockmutation has discrete effects on aging and carcinogenesisCell Cycle, 2008
- Differential display of DNA-binding proteins reveals heat-shock factor 1 as a circadian transcription factorGenes & Development, 2008
- Night Shift Work and the Risk of Endometrial CancerCancer Research, 2007
- Rb-Mediated Neuronal Differentiation through Cell-Cycle–Independent Regulation of E2f3aPLoS Biology, 2007
- System-Driven and Oscillator-Dependent Circadian Transcription in Mice with a Conditionally Active Liver ClockPLoS Biology, 2007
- Night work and breast cancer risk: A systematic review and meta-analysisEuropean Journal of Cancer, 2005
- Effects of meal timing on tumor progression in miceLife Sciences, 2004
- Chronic dietary restriction influences tumor metastasis in the rat: Parametric considerationsNutrition and Cancer, 1997